Our Mission

Founded in 2013, MetCure Therapeutics is a biotech startup focusing on early phase cancer drug discovery. MetCure has developed several lines of small-molecule lead compounds and a nutraceutical. MetCure also provides service in preclinical studies of target validation, toxicity and efficacy of your lead compounds using molecular, cellular and animal models.